These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4046133)

  • 21. Drug interaction between phenytoin and valproic acid in a child with refractory epilepsy: a case report.
    Carvalho IV; Carnevale RC; Visacri MB; Mazzola PG; de Fátima Lopes Ambrósio R; dos Reis MC; de Queiroz RA; Moriel P
    J Pharm Pract; 2014 Apr; 27(2):214-6. PubMed ID: 24381240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of phenytoin and folic acid.
    MacCosbe PE; Toomey K
    Clin Pharm; 1983; 2(4):362-9. PubMed ID: 6883965
    [No Abstract]   [Full Text] [Related]  

  • 23. Interaction of dietary pudding with phenytoin.
    Jann MW; Bean J; Fidone GS
    Pediatrics; 1986 Nov; 78(5):952-3. PubMed ID: 3763312
    [No Abstract]   [Full Text] [Related]  

  • 24. Interactions between anticonvulsants.
    Lander CM; Eadie MJ; Tyrer JH
    Proc Aust Assoc Neurol; 1975; 12():111-6. PubMed ID: 2912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comment: ciprofloxacin-phenytoin interaction.
    Pollak PT; Slayter KL
    Ann Pharmacother; 1997 Dec; 31(12):1549-50. PubMed ID: 9416402
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of serum levels during prolonged combination therapy with phenytoin and phenobarbitone.
    Müller FO; Aucamp AK; Hundt HK; Steyn JM; Olivier LR; Wessels WH
    S Afr Med J; 1977 Aug; 52(9):356-8. PubMed ID: 897947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic investigation of the interaction of azapropazone with phenytoin.
    Geaney DP; Carver JG; Davies CL; Aronson JK
    Br J Clin Pharmacol; 1983 Jun; 15(6):727-34. PubMed ID: 6871071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ticlopidine-induced phenytoin toxicity.
    Klaassen SL
    Ann Pharmacother; 1998 Dec; 32(12):1295-8. PubMed ID: 9876809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ciprofloxacin-phenytoin interaction.
    Brouwers PJ; de Boer LE; Guchelaar HJ
    Ann Pharmacother; 1997 Apr; 31(4):498. PubMed ID: 9101016
    [No Abstract]   [Full Text] [Related]  

  • 30. Tacrolimus-phenytoin interaction.
    Thompson PA; Mosley CA
    Ann Pharmacother; 1996 May; 30(5):544. PubMed ID: 8740340
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of dexamethasone on the decrease of serum phenytoin concentrations.
    Recuenco I; Espinosa E; García B; Carcas A
    Ann Pharmacother; 1995 Sep; 29(9):935. PubMed ID: 8547745
    [No Abstract]   [Full Text] [Related]  

  • 32. A potentially significant interaction between efavirenz and phenytoin: a case report and review of the literature.
    Robertson SM; Penzak SR; Lane J; Pau AK; Mican JM
    Clin Infect Dis; 2005 Jul; 41(2):e15-8. PubMed ID: 15983905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevation of plasma phenytoin by viloxazine in epileptic patients: a clinically significant drug interaction.
    Pisani F; Fazio A; Artesi C; Russo M; Trio R; Oteri G; Perucca E; Di Perri R
    J Neurol Neurosurg Psychiatry; 1992 Feb; 55(2):126-7. PubMed ID: 1538217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Letter: Phenytoin interference with dexamethasone.
    Boylan JJ; Owen DS; Chin JB
    JAMA; 1976 Feb; 235(8):803-4. PubMed ID: 946303
    [No Abstract]   [Full Text] [Related]  

  • 35. Lack of interaction between ranitidine and phenytoin.
    Watts RW; Hetzel DJ; Bochner F; Hallpike JF; Hann CS; Shearman DJ
    Br J Clin Pharmacol; 1983 Apr; 15(4):499-500. PubMed ID: 6303375
    [No Abstract]   [Full Text] [Related]  

  • 36. Interaction of chloramphenicol with phenytoin and phenobarbital. Case report.
    Koup JR; Gibaldi M; McNamara P; Hilligoss DM; Colburn WA; Bruck E
    Clin Pharmacol Ther; 1978 Nov; 24(5):571-5. PubMed ID: 699481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ciprofloxacin-phenytoin interaction.
    Dillard ML; Fink RM; Parkerson R
    Ann Pharmacother; 1992 Feb; 26(2):263. PubMed ID: 1554944
    [No Abstract]   [Full Text] [Related]  

  • 38. The binding of phenobarbitone and phenytoin to kwashiorkor serum.
    Buchanan N; van der Walt LA
    S Afr Med J; 1977 Sep; 52(13):518-21. PubMed ID: 72418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosage adjustments in response to monitored plasma concentrations: can unblinded staff adhere to objective criteria?
    Sahlroot JT; Pledger GW
    J Biopharm Stat; 1994 Mar; 4(1):91-100. PubMed ID: 8019586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenytoin-oxacillin interactions in normal and uremic sera.
    Dasgupta A; Sperelakis A; Mason A; Dean R
    Pharmacotherapy; 1997; 17(2):375-8. PubMed ID: 9085332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.